NDC 82982-032 – Hydroxyzine pamoate
Hydroxyzine Pamoate 25 mg/1 · Capsule · Oral
Product NDC82982-032
Product details
- Brand name
- Hydroxyzine pamoate
- Generic name
- Hydroxyzine pamoate
- Labeler
- Pharmasource Meds, LLC
- Dosage form
- Capsule
- Route
- Oral
- Marketing category
- ANDA · ANDA087479
- Marketed since
- February 27, 2023
- Marketing end
- November 30, 2026
- Pharmacologic class
- Antihistamine
Active ingredients
- Hydroxyzine Pamoate 25 mg/1
Uses, dosage, side effects and warnings for Hydroxyzine Pamoate →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 82982-032-30 | 30 CAPSULE in 1 BOTTLE (82982-032-30) | Feb 27, 2023 |
Other Hydroxyzine Pamoate products
- 50090-7540 Hydroxyzine Pamoate 50 mg/1 · Capsule · A-S Medication Solutions
- 50090-5933 Hydroxyzine Pamoate 50 mg/1 · Capsule · A-S Medication Solutions
- 50090-4579 Hydroxyzine Pamoate 25 mg/1 · Capsule · A-S Medication Solutions
- 50090-4385 Hydroxyzine Pamoate 25 mg/1 · Capsule · A-S Medication Solutions
- 60687-696 Hydroxyzine Pamoate 25 mg/1 · Capsule · American Health Packaging
- 60687-707 Hydroxyzine Pamoate 50 mg/1 · Capsule · American Health Packaging
- 0115-1803 Hydroxyzine Pamoate 25 mg/1 · Capsule · Amneal Pharmaceuticals of New York LLC
- 0115-1804 Hydroxyzine Pamoate 50 mg/1 · Capsule · Amneal Pharmaceuticals of New York LLC
- 71610-883 Hydroxyzine Pamoate 25 mg/1 · Capsule · Aphena Pharma Solutions - Tennessee, LLC
- 71610-773 Hydroxyzine Pamoate 25 mg/1 · Capsule · Aphena Pharma Solutions - Tennessee, LLC
- 71610-747 Hydroxyzine Pamoate 25 mg/1 · Capsule · Aphena Pharma Solutions - Tennessee, LLC
- 71610-217 Hydroxyzine Pamoate 25 mg/1 · Capsule · Aphena Pharma Solutions - Tennessee, LLC